Literature DB >> 27766250

Letter: Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:297-307).

Dongwon Yi1.   

Abstract

Entities:  

Year:  2016        PMID： 27766250      PMCID： PMC5069399          DOI： 10.4093/dmj.2016.40.5.418

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN： 2233-6079            Impact factor:   5.376


× No keyword cloud information.
  10 in total

1.  Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes.

Authors:  Michael A Crouch; Ivan N Mefford; Ekpedeme U Wade
Journal:  J Am Board Fam Med       Date:  2012 Jan-Feb       Impact factor: 2.657

Review 2.  Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis.

Authors:  Xiao-Meng Sun; Jia-Cheng Tan; Ying Zhu; Lin Lin
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

3.  Gastroesophageal reflux in diabetes mellitus.

Authors:  I Lluch; J F Ascaso; F Mora; M Minguez; A Peña; A Hernandez; A Benages
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

4.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

Review 5.  Review of gastroesophageal reflux disease (GERD) in the diabetic patient.

Authors:  Paawan Punjabi; Angela Hira; Shanti Prasad; Xiangbing Wang; Sita Chokhavatia
Journal:  J Diabetes       Date:  2015-04-30       Impact factor: 4.006

Review 6.  Gastrointestinal complications of diabetes.

Authors:  Brigid S Boland; Steven V Edelman; James D Wolosin
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09-24       Impact factor: 4.741

7.  Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy.

Authors:  Xiangbing Wang; C S Pitchumoni; Khushbu Chandrarana; Neha Shah
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Authors:  Pawan Kumar Singh; Debasish Hota; Pinaki Dutta; Naresh Sachdeva; Amitava Chakrabarti; Anand Srinivasan; Inderjeet Singh; Anil Bhansali
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

9.  The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease.

Authors:  Tiberiu Hershcovici; Lokesh K Jha; Rakshith Gadam; Haiyan Cui; Lauren Gerson; Stephen Thomson; Ronnie Fass
Journal:  J Clin Gastroenterol       Date:  2012-09       Impact factor: 3.062

10.  Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus.

Authors:  Jun Ouk Ha; Tae Hee Lee; Chang Won Lee; Ja Young Park; Seong Ho Choi; Hee Seung Park; Jae Seung Lee; Seung Heon Lee; Eun Hee Seo; Young Hwan Kim; Young Woo Kang
Journal:  Diabetes Metab J       Date:  2016-06-08       Impact factor: 5.376
  10 in total
  1 in total

1.  The effect of proton pump inhibitors on glycaemic control in diabetic patients.

Authors:  Muhammad Ali Rajput; Fizzah Ali; Tabassum Zehra; Shahid Zafar; Gunesh Kumar
Journal:  J Taibah Univ Med Sci       Date:  2020-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.